2023 Stem Cells and Cancer Gordon Research Conference and Seminar

2023年干细胞与癌症戈登研究会议暨研讨会

基本信息

  • 批准号:
    10683590
  • 负责人:
  • 金额:
    $ 0.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-06 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY This proposal requests partial support for the eighth Gordon Research Conference on Stem Cells and Cancer, which will take place on May 14-19, 2023 in Lucca (Italy). The goal of this conference is to provide a forum for presentation, discussion and interaction among a diverse, interdisciplinary group of researchers with interests in stem cell biology, development, and cancer. In particular, we wish to highlight how principles taken from development can be used to better understand tumor initiation and metastasis. The meeting is chaired by Dr. Cedric Blanpain (Université Libre de Bruxelles), with Drs. Leanne Jones (UCSF) and Kathrin Plath (UCLA) serving as vice chairs. The planned agenda includes presentations from key leaders in the fields of cancer biology, stem cell biology and regenerative medicine, and thus will attract a highly interdisciplinary group of researchers who do not frequently interact at meetings. This meeting will, therefore, act as a catalyst for new collaborations and cross-fertilization of ideas, which is, of course, a long-term goal of the Gordon Research Conferences. The outstanding scientific program for the meeting highlights the diversity of contributors to this research area (48% of invited speakers are female and/or members of under-represented minority groups) and explores cutting-edge topics of particular interest to the National Institutes of Health (NIH), including but not limited to: developmental mechanisms known to regulate stem cell fate decisions and tissue homeostasis that are usurped for tumor formation, the role of metabolism in regulating stem cells, tissue homeostasis and tumor growth, and emerging therapies to promote tumor cell clearance, eradicate tumor-propagating stem cells and enhance organ repair. Additional speakers will be chosen from the submitted abstracts, with particular consideration given to those investigators from backgrounds traditionally underrepresented in the sciences. The 2023 Gordon Research Conference on Stem Cells and Cancer will also include a Gordon Research Seminar (GRS), a 2-day “pre-meeting” of early career scientists in a highly stimulating and inclusive environment that promotes the open exchange of information and establishment and growth of peer networks. The GRS will be held from May 12-13, 2023 at the same venue in Lucca, and is chaired by Dr. Tugba Topal (Univ. of Michigan) and supported by an organizing committee of three doctoral students: Clara Cano (UCLA), Andrea Pérez González (Université Libre de Bruxelles), and Nicholas Jackson (UCSF). The GRS provides additional opportunities for junior trainees to present their work and receive crucial feedback and mentorship both from their peers and from more established investigators, making this meeting a particularly valuable training opportunity for junior investigators. The specific set of integrated and complementary research topics that will be addressed in the 2023 Stem Cells and Cancer GRS/GRC is distinct from other conferences, and the unique structure of the GRS and GRC provides for productive interactions among scientists and trainees at different career stages in industry and academia who are addressing fundamental questions in the area using different experimental approaches.
项目总结 这项提议要求部分支持第八届戈登干细胞研究会议和 癌症,将于2023年5月14日至19日在意大利卢卡举行。这次会议的目标是提供一个 为不同的跨学科研究人员小组提供演示、讨论和互动的论坛 对干细胞生物学、发育和癌症感兴趣。我们特别要强调的是,原则是如何 可以用来更好地了解肿瘤的起始和转移。会议由以下人员主持 塞德里克·布兰佩恩博士(自由大学)、利安·琼斯博士(加州大学洛杉矶分校)和凯瑟琳·普拉斯博士(加州大学洛杉矶分校) 担任副主席。计划中的议程包括癌症领域主要领导人的演讲 生物学、干细胞生物学和再生医学,因此将吸引一个高度跨学科的小组 不经常在会议上互动的研究人员。因此,这次会议将成为新的 当然,这是戈登研究中心的长期目标 会议。这次会议杰出的科学计划突显了贡献者的多样性。 研究区(48%的受邀发言者是女性和/或代表性不足的少数群体成员)和 探索美国国立卫生研究院(NIH)特别感兴趣的前沿话题,包括但不是 仅限于:已知的调节干细胞命运决定的发育机制和组织动态平衡 被篡夺用于肿瘤形成、新陈代谢在调节干细胞、组织动态平衡和肿瘤中的作用 生长,以及促进肿瘤细胞清除、根除肿瘤增殖干细胞和 加强器官修复。其他发言者将从提交的摘要中选出,特别是 考虑到那些来自传统上在科学界代表性较低的背景的调查人员。这个 2023年戈登干细胞与癌症研究会议还将包括戈登研究研讨会 (GRS),这是一个为期两天的早期职业科学家在高度刺激和包容的环境中的“预会”, 促进信息的公开交流和同行网络的建立和发展。GRS将是 于2023年5月12日至13日在卢卡的同一地点举行,由Tugba Topal博士(Uni.密歇根州) 并得到了由三名博士生组成的组织委员会的支持:克拉拉·卡诺(加州大学洛杉矶分校)、安德里亚·佩雷斯 González(自由大学)和Nicholas Jackson(加州大学旧金山分校)。GRS提供了额外的 初级实习生有机会介绍他们的工作,并从以下两个方面获得重要的反馈和指导 他们的同行和更成熟的调查人员,使这次会议成为一次特别有价值的培训 初级调查员的机会。一套具体的综合性和互补性研究主题将是 在2023年干细胞和癌症GRS/GRC上发表的演讲有别于其他会议,并且是独一无二的 GRS和GRC的结构为不同领域的科学家和受训者提供了富有成效的互动 在工业界和学术界的职业生涯阶段,他们正在使用不同的方法解决该领域的基本问题 实验方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathrin Plath其他文献

Kathrin Plath的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathrin Plath', 18)}}的其他基金

Epigenetic control of the human X chromosome
人类 X 染色体的表观遗传控制
  • 批准号:
    10152632
  • 财政年份:
    2019
  • 资助金额:
    $ 0.7万
  • 项目类别:
Epigenetic control of the human X chromosome
人类 X 染色体的表观遗传控制
  • 批准号:
    10397572
  • 财政年份:
    2019
  • 资助金额:
    $ 0.7万
  • 项目类别:
Epigenetic control of the human X chromosome
人类 X 染色体的表观遗传控制
  • 批准号:
    9921448
  • 财政年份:
    2019
  • 资助金额:
    $ 0.7万
  • 项目类别:
Epigenetic control of the human X chromosome
人类 X 染色体的表观遗传控制
  • 批准号:
    10620130
  • 财政年份:
    2019
  • 资助金额:
    $ 0.7万
  • 项目类别:
Mechanism of chromatin remodeling and gene silencing by the lncRNAs Xist and Tsix
lncRNA Xist 和 Tsix 的染色质重塑和基因沉默机制
  • 批准号:
    9531581
  • 财政年份:
    2015
  • 资助金额:
    $ 0.7万
  • 项目类别:
Mechanism of chromatin remodeling and gene silencing by the lncRNAs Xist and Tsix
lncRNA Xist 和 Tsix 的染色质重塑和基因沉默机制
  • 批准号:
    8988214
  • 财政年份:
    2015
  • 资助金额:
    $ 0.7万
  • 项目类别:
Project 1: Defining the Logic of Genome Organization In Pluripotent Cells
项目 1:定义多能细胞基因组组织的逻辑
  • 批准号:
    8710263
  • 财政年份:
    2014
  • 资助金额:
    $ 0.7万
  • 项目类别:
Core B: Administrative Core
核心 B:行政核心
  • 批准号:
    8710268
  • 财政年份:
    2014
  • 资助金额:
    $ 0.7万
  • 项目类别:
Project 1: Defining the Logic of Genome Organization In Pluripotent Cells
项目 1:定义多能细胞基因组组织的逻辑
  • 批准号:
    8520349
  • 财政年份:
    2013
  • 资助金额:
    $ 0.7万
  • 项目类别:
Core B: Administrative Core
核心 B:行政核心
  • 批准号:
    8520354
  • 财政年份:
    2013
  • 资助金额:
    $ 0.7万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了